As of 2026-05-30, the Fair Value of Oncology Pharma Inc (ONPH) is -4.06 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.06 USD, the upside of Oncology Pharma Inc is -6,697.65%.
With the market price of 0.06 USD and our fair value calculation, Oncology Pharma Inc (ONPH) is not a good investment. Investing in ONPH stocks now will result in a potential loss of 6,697.65%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2003-03-31 | 2004-03-31 | 2011-06-30 | 2011-09-30 | 2013-03-31 | 5Y Avg | |
| Net income | -1.52 | -1.56 | 0.06 | 0.07 | -0.19 | -0.63 |
| YoY growth | 22.09% | -2.96% | 103.75% | 19.50% | -365.09% | -44.54% |
| Market Cap (mil) | 1.68 |
| P/E | |
| Forward P/E |
| EPS | -0.81 |
| Avg earnings growth rate | -44.54% |
| TTM earnings | -22.19 |